111 Michigan Ave, NW, Washington, DC, 20010 · (202) 476-5000
Beds
323
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$1.61B
FY 2025
Net income
$102.1M
Patient care margin -7.8%
Discharges
13,243
Occupancy 88.3%
Clinicians
27
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.61B | $1.74B | -7.8% | $102.1M | 13,243 | - | 0.3% | 14.6% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 5113 Level 3 Musculoskeletal Procedures |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $1.44B | $1.59B | -10.7% | $84.7M | 13,654 | - | 0.1% | 14.0% |
| 2023 | $1.36B | $1.47B | -8.2% | $61.8M | 13,762 | - | 0.1% | 12.4% |
| 2022 | $1.24B | $1.37B | -10.8% | $43.4M | 14,343 | - | 0.1% | 13.0% |
| 2021 | $1.11B | $1.24B | -11.8% | $44.0M | 12,229 | - | 0.3% | 15.2% |
| 2020 | $1.06B | $1.33B | -26.0% | $7.6M | 14,421 | - | 0.3% | 16.0% |
| - |
| - |
| - |
| $2,373.24 |
| APC 5191 Level 1 Endovascular Procedures | - | - | - | $2,207.96 |
| APC 5302 Level 2 Upper GI Procedures | - | - | - | $1,444.50 |
| APC 5463 Level 3 Neurostimulator and Related Procedures | - | - | - | $11,549.97 |
| APC 8011 Comprehensive Observation Services | - | - | - | $2,090.36 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 17 | $736K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $654K |
| MED-EL Corporation | 1 | $66K |
| Berlin Heart Inc | 2 | $15K |
| Qiagen, LLC | 1 | $10K |
| National Marrow Donor Program | 5 | $8,915 |
| Siemens Medical Solutions USA, Inc. SHL.DE | 2 | $5,191 |
| Merck Sharp & Dohme LLC MRK | 2 | $5,000 |
| Pfizer Inc. PFE | 2 | $5,000 |
| Neurelis, Inc. | 2 | $4,200 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Children's National Hospital is a nonprofit children's hospital in Washington, DC with 323 beds, part of Childrens National Health System.
Children's National Hospital in Washington, DC has 323 beds (fiscal year 2025 cost report). It discharged 13,243 inpatients that year, with 88.3% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Children's National Hospital reported net patient revenue of $1.61B and operating expenses of $1.74B, a margin on patient care of -7.8%. After other income and expenses its net income was $102.1M (5.5% of revenue), so it made a profit that year.
Children's National Hospital is part of Childrens National Health System, a health system with 1 hospitals based in Washington, DC. It is a nonprofit hospital.
Children's National Hospital has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Children's National Hospital provides emergency services.
27 Medicare clinicians list Children's National Hospital as a hospital they work at, most often in Pediatric Medicine, Diagnostic Radiology, Cardiovascular Disease (Cardiology).
In 2025, companies reported $1.5M in payments to Children's National Hospital as a teaching hospital ($784K general and $754K for research) from 24 companies.